Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis

Nature Cell Biology

Volumn 17, Issue 2, 2015, Pages 183-194

  Fong, Miranda Y ^a   Zhou, Weiying ^a   Liu, Liang ^a,b   Alontaga, Aileen Y ^a   Chandra, Manasa ^a   Ashby, Jonathan ^c   Chow, Amy ^a   O'Connor, Sean Timothy Francis ^a   Li, Shasha ^a   Chin, Andrew R ^a   Somlo, George ^a   Palomares, Melanie ^a   Li, Zhuo ^a   Tremblay, Jacob R ^a   Tsuyada, Akihiro ^a   Sun, Guoqiang ^a   Reid, Michael A ^a   Wu, Xiwei ^a   Swiderski, Piotr ^a   Ren, Xiubao ^b   Shi, Yanhong ^a   Kong, Mei ^a   Zhong, Wenwan ^c   Chen, Yuan ^a   Wang, Shizhen Emily ^a,b   more..

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 122; PYRUVATE KINASE; BROXURIDINE; GLUCOSE; LUCIFERASE; MICRORNA; MIRN122 MICRORNA, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME REGULATION; FEMALE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METABOLIC REGULATION; METASTASIS; MOUSE; NONHUMAN; NUTRIENT AVAILABILITY; TUMOR PROMOTION; ASTROCYTE; BREAST TUMOR; CELL PROLIFERATION; DOWN REGULATION; EXOSOME; FIBROBLAST; GENETICS; LUNG; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; SECRETION (PROCESS); TUMOR CELL LINE; ULTRASTRUCTURE;

ASTROCYTES; BASE SEQUENCE; BREAST NEOPLASMS; BROMODEOXYURIDINE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; EXOSOMES; FEMALE; FIBROBLASTS; GLUCOSE; HUMANS; LUCIFERASES; LUNG; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; PYRUVATE KINASE;

EID: 84923194150     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3094     Document Type: Article

References (69)

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646-674 (2011).
2. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009).
3. Zhao, F. Q. & Keating, A. F. Functional properties and genomics of glucose transporters. Curr. Genomics 8, 113-128 (2007).
4. DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. & Thompson, C. B. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11-20 (2008).
5. Barthel, A. et al. Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J. Biol. Chem. 274, 20281-20286 (1999).
6. O'Rourke, J. F., Pugh, C. W., Bartlett, S. M. & Ratcliffe, P. J. Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR. Role of hypoxia-inducible factor-1. Eur. J. Biochem. 241, 403-410 (1996).
7. Semenza, G. L., Roth, P. H., Fang, H. M. & Wang, G. L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757-23763 (1994).
8. Spoden, G. A. et al. The SUMO-E3 ligase PIAS3 targets pyruvate kinase M2. J. Cell Biochem. 107, 293-302 (2009).
9. Yang, W. et al. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat. Cell Biol. 14, 1295-1304 (2012).
10. Gao, X., Wang, H., Yang, J. J., Liu, X. & Liu, Z. R. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol. Cell 45, 598-609 (2012).
11. Yang, W. et al. Nuclear PKM2 regulates-catenin transactivation upon EGFR activation. Nature 480, 118-122 (2011).
12. Lee, J., Kim, H. K., Han, Y. M. & Kim, J. Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription. Int. J. Biochem. Cell Biol. 40, 1043-1054 (2008).
13. Luo, W. et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxiainducible factor 1. Cell 145, 732-744 (2011).
14. Bartel, D. P. MicroRNAs: Target recognition and regulatory functions. Cell 136, 215-233 (2009).
15. Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866 (2006).
16. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA 105, 10513-10518 (2008).
17. Taylor, D. D. & Gercel-Taylor, C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110, 13-21 (2008).
18. Wu, X. et al. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer. J. Transl. Med. 10, 42 (2012).
19. Zhu, W., Qin, W., Atasoy, U. & Sauter, E. R. Circulating microRNAs in breast cancer and healthy subjects. BMC Res. Notes 2, 89 (2009).
20. Zen, K. & Zhang, C. Y. Circulating microRNAs: A novel class of biomarkers to diagnose and monitor human cancers. Med. Res. Rev. 32, 326-348 (2012).
21. Redis, R. S., Calin, S., Yang, Y., You, M. J. & Calin, G. A. Cell-to-cell miRNA transfer: From body homeostasis to therapy. Pharmacol. Ther. 136, 169-174 (2012).
22. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007).
23. Wang, K., Zhang, S., Weber, J., Baxter, D. & Galas, D. J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 38, 7248-7259 (2010).
24. Vickers, K. C. & Remaley, A. T. Lipid-based carriers of microRNAs and intercellular communication. Curr. Opin. Lipidol. 23, 91-97 (2012).
25. Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476 (2008).
26. Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891 (2012).
27. Zhou, W. et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 25, 501-515 (2014).
28. Rottiers, V. & Naar, A. M. MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 13, 239-250 (2012).
29. Moore, K. J., Rayner, K. J., Suarez, Y. & Fernandez-Hernando, C. The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu. Rev. Nutr. 31, 49-63 (2011).
30. Boutz, D. R. et al. Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. J. Biol. Chem. 286, 18066-18078 (2011).
31. Palma, J. et al. MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res. 40, 9125-9138 (2012).
32. Ashby, J. et al. Distribution profiling of circulating MicroRNAs in serum. Anal. Chem. 86, 9343-9349 (2014).
33. Lloyd, P. G., Hardin, C. D. & Sturek, M. Examining glucose transport in single vascular smooth muscle cells with a fluorescent glucose analog. Physiol. Res. 48, 401-410 (1999).
34. Loaiza, A., Porras, O. H. & Barros, L. F. Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy. J. Neurosci. 23, 7337-7342 (2003).
35. Yamada, K. et al. Measurement of glucose uptake and intracellular calcium concentration in single, living pancreatic-cells. J. Biol. Chem. 275, 22278-22283 (2000).
36. Itoh, Y., Abe, T., Takaoka, R. & Tanahashi, N. Fluorometric determination of glucose utilization in neurons in vitro and in vivo. J. Cereb. Blood Flow Metab. 24, 993-1003 (2004).
37. Chuquet, J., Quilichini, P., Nimchinsky, E. A. & Buzsaki, G. Predominant enhancement of glucose uptake in astrocytes versus neurons during activation of the somatosensory cortex. J. Neurosci. 30, 15298-15303 (2010).
38. Bak, L. K., Schousboe, A., Sonnewald, U. & Waagepetersen, H. S. Glucose is necessary to maintain neurotransmitter homeostasis during synaptic activity in cultured glutamatergic neurons. J. Cereb. Blood Flow Metab. 26, 1285-1297 (2006).
39. Hu, M. et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 13, 394-406 (2008).
40. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D. & Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433 (2011).
41. Arroyo, J. D. et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl Acad. Sci. USA 108, 5003-5008 (2011).
42. Pavlides, S. et al. The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8, 3984-4001 (2009).
43. Martinez-Outschoorn, U. E., Lisanti, M. P. & Sotgia, F. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin. Cancer Biol. 25, 47-60 (2014).
44. Kaplan, R. N., Psaila, B. & Lyden, D. Bone marrow cells in the ?pre-metastatic niche': Within bone and beyond. Cancer Metastasis Rev. 25, 521-529 (2006).
45. Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827 (2005).
46. Peinado, H., Lavotshkin, S. & Lyden, D. The secreted factors responsible for premetastatic niche formation: Old sayings and new thoughts. Semin. Cancer Biol. 21, 139-146 (2011).
47. Sethi, N. & Kang, Y. Unravelling the complexity of metastasis-molecular understanding and targeted therapies. Nat. Rev. Cancer 11, 735-748 (2011).
48. Hood, J. L., San, R. S. & Wickline, S. A. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 71, 3792-3801 (2011).
49. Grange, C. et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 71, 5346-5356 (2011).
50. Erler, J. T. et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35-44 (2009).
51. Hiratsuka, S. et al. Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci. Nat. Commun. 4, 1853 (2013).
52. Hiratsuka, S. et al. Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation. Proc. Natl Acad. Sci. USA 108, 3725-3730 (2011).
53. Hiratsuka, S., Watanabe, A., Aburatani, H. & Maru, Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369-1375 (2006).
54. Hiratsuka, S. et al. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 10, 1349-1355 (2008).
55. Bos, R. et al. Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J. Clin. Oncol. 20, 379-387 (2002).
56. Kang, S. S. et al. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J. Cancer Res. 93, 1123-1128 (2002).
57. Elmen, J. et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 36, 1153-1162 (2008).
58. Elmen, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899 (2008).
59. Takanaga, H. & Frommer, W. B. Facilitative plasma membrane transporters function during ER transit. FASEB J. 24, 2849-2858 (2010).
60. Wang, Y. et al. Transforming growth factor-regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene 30, 1470-1480 (2011).
61. Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. (2006).
62. Tsuyada, A. et al. CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res. 72, 2768-2779 (2012).
63. Yu, Y. et al. Context-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor beta contributes to chemoresistance in breast cancer cells. Mol. Cancer Res. 8, 1633-1642 (2010).
64. Clower, C. V. et al. The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc. Natl Acad. Sci. USA 107, 1894-1899 (2010).
65. Edwards, R. J. & Watts, D. C. Specific spectrophotometric assay for the M isoenzymes of pyruvate kinase in plasma samples containing mixtures of the muscle (M) and liver (L) isoenzymes. Clin. Chem. 27, 906-909 (1981).
66. Cano, K. E., Li, Y. J. & Chen, Y. NMR metabolomic profiling reveals new roles of SUMOylation in DNA damage response. J. Proteome Res. 9, 5382-5388 (2010).
67. Chida, J., Yamane, K., Takei, T. & Kido, H. An efficient extraction method for quantitation of adenosine triphosphate in mammalian tissues and cells. Anal. Chim. Acta 727, 8-12 (2012).
68. Fong, M. Y. et al. Withaferin a synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer. PLoS ONE 7, e42265 (2012).
69. Jorgensen, S., Baker, A., Moller, S. & Nielsen, B. S. Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 52, 375-381 (2010).